Drug Trial News

RSS

New studies examine use of the nucleoside polymerase inhibitor, R1626, to the standard therapy for hepatitis C

Two new studies examine the use of the nucleoside polymerase inhibitor, R1626, to the standard therapy for hepatitis C. The reports appear in the August issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD).

31 Jul 2008

study shows compounds from soy affect brain and reproductive development

Two hormone-like compounds linked to the consumption of soy-based foods can cause irreversible changes in the structure of the brain, resulting in early-onset puberty and symptoms of advanced menopause in research animals, according to a new study by researchers at North Carolina State University. The study is a breakthrough in determining how these compounds can cause reproductive health problems, as well as in providing a key building block for how to treat these problems.

31 Jul 2008

Study reveals cost of stabbings to British health service

Injuries caused by gun and knife crime are costing Britain's National Health Service in excess of £3million a year, new research reveals.

From The University of Manchester 31 Jul 2008

What do doctors tell patients about the survival benefits of palliative chemotherapy?

Two thirds of cancer patients may receive little or no information about the survival benefits of having palliative chemotherapy before making a decision about treatment, according to a study by researchers at Bristol University published today on bmj.com.

31 Jul 2008

Drug use by Europe's youth leads to risky sexual behaviour

High levels of alcohol and drug consumption by young people in Europe is leading to an increase in unsafe sexual practices and a consequent rise in sexually-transmitted disease infections, according to a recently published study by the European Institute of Studies on Prevention (IREFREA).

31 Jul 2008

Study sheds light on why addiction is a chronic disease

Drug addiction dramatically shifts a person's attention, priorities, and behaviors towards a focus almost entirely on seeking out and taking drugs. Now, an animal study funded by the National Institute on Drug Abuse, part of the National Institutes of Health, has identified some of the specific long-term adaptations in the brain's reward system that may contribute to this shift.

31 Jul 2008

Warfarin may prevent liver failure in hepatitis C

The drug warfarin may help prevent liver failure in thousands of people with Hepatitis C, according to new research.

31 Jul 2008

Living with someone reduces risk of developing Alzheimer's

Living with a spouse or a partner decreases the risk of developing Alzheimer's and other dementia diseases. This according to a study by Krister Hakansson, researcher in psychology at Vaxjo University and Karolinska Institutet, Sweden.

31 Jul 2008

Metabolic syndrome and alcohol comsumption

Those who drink in excess of the U.S. Dietary Guidelines (i.e., men who usually drink more than two drinks per day or women who usually drink more than one drink per day) or those who binge drink are at increased risk for the metabolic syndrome, according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

31 Jul 2008

Excess fat around the heart may be worse than high BMI for heart attacks

When it comes to risk for a heart attack, having excess fat around the heart may be worse than having a high body mass index or a thick waist, according to researchers from Wake Forest University Baptist Medical Center and colleagues reporting in the August issue of the journal Obesity.

31 Jul 2008

Survey reveals most drinkers exceed current safe alcohol guidelines

According to a new study people who drink more than the guidelines for safe alcohol consumption place themselves at risk of developing metabolic syndrome.

30 Jul 2008

Genetic clues to schizophrenia uncovered

New research has found genetic flaws which scientists say are about 15 percent more frequent in people with schizophrenia.

30 Jul 2008

Stanford Medicine explores the complex world of clinical trials

Back just 100 years ago, the notion of testing treatments and drugs through randomized clinical trials was unheard of. Clinical trials began to proliferate only in 1800, placebos were first used in 1863 and randomization wasn't introduced until 1923.

30 Jul 2008

Promising new therapy for Alzheimer's

NewYork-Presbyterian Hospital/Weill Cornell Medical Center announced today the nine-month interim results of an ongoing Phase II clinical trial of GAMMAGARD Intravenous Immunoglobulin (IGIV) for Alzheimer's disease at the Alzheimer's Association International Conference on Alzheimer's Disease (ICAD) in Chicago.

From Baxter International Inc. 30 Jul 2008

Rember, new Alzheimer's drug offers hope to sufferers

An experimental drug to treat Alzheimer's disease has had some promising results in early trials with patients.

30 Jul 2008

Retirement could be hazardous for the health

A study by the ABS based on 2004-05 health data and labour force statistics on older workers aged 45 to 74, also took into account people not in the workforce and those too ill to work.

30 Jul 2008

Twenty percent of British adult survivors of childhood cancer smoke despite hazards

Twenty percent of British adult survivors of childhood cancers are current smokers, and nearly a third have been regular smokers at some point in their lives, according to a study in the July 29 online issue of the Journal of the National Cancer Institute.

29 Jul 2008

Cholesterol lowering drugs may protect against dementia

A new study has found more evidence that the drugs commonly used to lower cholesterol may also offer protection from dementia and memory loss.

29 Jul 2008

Bladder problems may leave mark on brain contributing to sleep and attention problems

Bladder problems may leave a mark on the brain, by changing patterns of brain activity, possibly contributing to disrupted sleep and problems with attention. For one in six Americans who have overactive bladder, the involuntary bladder contractions that often trigger more frequent urges to urinate, such mind-body connections may be of more than academic interest.

29 Jul 2008

Australian Alzheimer's trial published in the Lancet

Prana Biotechnology Limited announced today the publication of the results of its Phase 2a clinical trial on Alzheimer's disease patients in The Lancet Neurology journal.

29 Jul 2008